T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy
Journal article published in 2024 by
Guido Ghilardi,
Joseph A. Fraietta 
,
James N. Gerson,
Vivianna M. Van Deerlin ,
Jennifer J. D. Morrissette,
Gabriel C. Caponetti ,
Luca Paruzzo,
Jaryse C. Harris,
Elise A. Chong ,
Sandra P. Susanibar Adaniya ,
Jakub Svoboda,
Sunita D. Nasta,
Ositadimma H. Ugwuanyi,
Daniel J. Landsburg,
Eugenio Fardella
and other authors.
,
James N. Gerson,
Vivianna M. Van Deerlin ,
Jennifer J. D. Morrissette,
Gabriel C. Caponetti ,
Luca Paruzzo,
Jaryse C. Harris,
Elise A. Chong ,
Sandra P. Susanibar Adaniya ,
Jakub Svoboda,
Sunita D. Nasta,
Ositadimma H. Ugwuanyi,
Daniel J. Landsburg,
Eugenio Fardella
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 